About

Transcatheter therapy of structural heart disease is advancing rapidly. Due to the less invasive approach, transcatheter techniques have replaced surgery as the standard procedure for atrial septal defect and patent foramen ovale closure.

Evolving interventional techniques allow treatment of paravalvular leaks, ventricular septal defects and valve replacement, especially the rapid evolution and newer indications for transcatheter aortic valve replacement (TAVR).

Related Articles

Articles

Comments on TARGET FFR and DEFINE-FLOW Trials Presented at TCT Connect 2020

Andreas Seitz, Stefan Baumann, Udo Sechtem,

Published:

Citation: European Cardiology Review 2021;16:e17.

Contemporary Management of Isolated Ostial Side Branch Disease

Suleiman Suleiman, JJ Coughlan, George Touma,

Published:

Citation: Interventional Cardiology Review 2021;16:e06.

Frailty Scores and CVD

Kenneth Jordan Ng Cheong Chung, Chris Wilkinson, Murugapathy Veerasamy,

Published:

Citation: Interventional Cardiology Review 2021;16:e05.

Editorial: The EXCEL Trial

Pablo Avanzas, Juan Carlos Kaski,

Published:

Citation: European Cardiology Review 2021;16:e09.